BPC-157/TB-500 Blend

About BPC-157/TB-500 Blend

A combination blend of BPC-157 and TB-500 peptides used in research applications studying synergistic effects in tissue repair and cellular regeneration.

This research peptide is supplied as a lyophilized powder that requires reconstitution before use in laboratory applications. It is provided at research-grade purity for in-vitro studies only.

Research Applications: BPC-157/TB-500 Blend is used exclusively for laboratory research purposes. It is not intended for human consumption, medical treatment, or any form of in-vivo application.

Storage: Store lyophilized powder at -20°C. After reconstitution, store at 2-8°C and use within the timeframe specified by the manufacturer.

Detailed Research Information

BPC-157/TB-500 Blend combines two prominent healing peptides studied extensively in tissue repair and regenerative medicine research. As a research compound, this combination is investigated for potential synergistic effects on wound healing, tissue regeneration, and anti-inflammatory mechanisms.

Key Research Applications

Synergistic Healing Research: The BPC-157/TB-500 blend is utilized in studies examining combined effects on tissue repair, investigating whether simultaneous administration produces additive or synergistic healing responses.

Angiogenesis Studies: Research applications include investigation of combined effects on blood vessel formation, examining VEGF pathway activation and endothelial cell migration enhancement through dual peptide mechanisms.

Musculoskeletal Research: The blend is employed in studies exploring tendon, ligament, and muscle injury models, examining combined effects on collagen synthesis, fibroblast activation, and structural tissue repair.

Anti-inflammatory Research: Studies utilize the BPC-157/TB-500 combination to investigate dual anti-inflammatory mechanisms, examining effects on cytokine production, immune cell infiltration, and inflammation resolution pathways.

Mechanism of Action

The BPC-157/TB-500 blend combines two distinct mechanisms of action. BPC-157 functions through promotion of angiogenesis via VEGF receptor modulation, stabilization of the JAK-STAT pathway, and potential interactions with nitric oxide pathways. TB-500 (Thymosin Beta-4 fragment) works through actin sequestration promoting cellular migration, upregulation of matrix metalloproteinases facilitating tissue remodeling, and direct effects on endothelial cell differentiation. Research suggests that combined administration may produce complementary effects on different aspects of the healing cascade, though systematic studies directly comparing combination versus individual peptide effects remain limited.

Product Specifications

All listed research peptides are supplied in lyophilized (freeze-dried) powder form and require reconstitution with bacteriostatic water or sterile water before use in laboratory applications. Products are intended exclusively for in vitro research and are not for human consumption.